Med-Tech Innovation August 7, 2024
Partnership Expands Reach of C2N’s Precivity Blood Tests in Over 75 Countries to Transform Alzheimer’s Disease Early Diagnosis and Research.
Unilabs, a leading international provider of diagnostic services, and C2N Diagnostics, LLC, a specialist in advanced diagnostic solutions in the field of Alzheimer’s disease and related neurological disorders, have announced what the companies say is a major milestone in brain health diagnostics and research across Europe and beyond.
Unilabs and C2N have signed a multi-year partnership agreement that will increase access to C2N’s Precivity portfolio of blood tests on an exclusive basis in Europe, including Norway, Switzerland, and the United Kingdom. The agreement will also provide access in Peru, Saudi Arabia, and the United Arab Emirates.
“Alzheimer’s disease is...
Today's Sponsors
Today's Sponsor